Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

ENTX

Entera Bio Ltd

Feb 13 • 04:00PM ET

1.50

-0.02 -1.32 %

Healthcare • Biotechnology • Israel • NASD

Peers: JNJ LLY AMGN BMY PFE SNY VRTX BIIB GSK NBIX

Index	-	P/E	-	EPS (ttm)	-0.24	Insider Own	24.67%	Shs Outstand	45.66M	Perf Week	44.23%
Market Cap	68.79M	Forward P/E	-	EPS next Y	-0.68	Insider Trans	0.35%	Shs Float	34.54M	Perf Month	-7.98%
Enterprise Value	52.40M	PEG	-	EPS next Q	-0.09	Inst Own	19.97%	Short Float	0.30%	Perf Quarter	-48.45%
Income	-10.78M	P/S	573.25	EPS this Y	-12.00%	Inst Trans	-2.62%	Short Ratio	0.53	Perf Half Y	-23.86%
Sales	0.12M	P/B	4.50	EPS next Y	-142.86%	ROA	-85.74%	Short Interest	0.10M	Perf YTD	-22.68%
Book/sh	0.33	P/C	4.14	EPS next 5Y	-	ROE	-99.43%	52W High	3.22 -53.42%	Perf Year	-34.50%
Cash/sh	0.36	P/FCF	-	EPS past 3/5Y	18.40% 22.19%	ROIC	-70.58%	52W Low	1.00 50.00%	Perf 3Y	66.69%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-31.82% -5.17%	Gross Margin	-12.10%	Volatility	14.27% 11.32%	Perf 5Y	-18.03%
Dividend TTM	-	EV/Sales	436.67	EPS Y/Y TTM	5.96%	Oper. Margin	-8729.03%	ATR (14)	0.18	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	10.83	Sales Y/Y TTM	25.25%	Profit Margin	-8694.35%	RSI (14)	49.52	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	10.83	EPS Q/Q	15.21%	SMA20	4.38%	Beta	1.81	Target Price	10.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-100.00%	SMA50	-11.47%	Rel Volume	0.36	Prev Close	1.52
Employees	20	LT Debt/Eq	0.00	Earnings	Nov 14 AMC	SMA200	-25.57%	Avg Volume	193.15K	Price	1.50
IPO	Jun 28, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	22.22% -	Trades		Volume	68,890	Change	-1.32%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-22-21	Initiated	Aegis Capital	Buy	$12

Feb-11-26 09:00AM	Entera Bio Announces Open Market Purchases of Company Stock by Board Members (GlobeNewswire) +13.10%
Feb-09-26 08:50AM	Entera Bio Appoints Former Pfizer Executive Geno J. Germano as Chairman of the Board Ahead of Key Milestones (GlobeNewswire) +27.88%
Feb-04-26 08:00AM	OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism (GlobeNewswire)
Jan-21-26 08:30AM	Entera Bio Announces Upcoming Q1 2026 Corporate Priorities and Pipeline Outlook (GlobeNewswire)
Dec-23-25 08:30AM	Entera Bio Congratulates the FNIH-ASBMR-SABRE Team on FDA's Qualification of Total Hip BMD as Regulatory Endpoint: Huge Win for Osteoporosis Innovation (GlobeNewswire) -6.38%
08:30AM	Loading…
Dec-22-25 08:30AM	Entera Bio Announces New Data Supporting Further Development of a Proprietary First-in-Class Oral, Long-Acting PTH Tablet for Patients with Hypoparathyroidism (EB612 Program) (GlobeNewswire) +6.21%
Nov-18-25 08:00AM	Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference (GlobeNewswire)
Nov-14-25 04:05PM	Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
Oct-23-25 08:50AM	Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women (GlobeNewswire) -6.96%
Oct-16-25 08:45AM	Entera Bio to Present New Clinical Data from Phase 2 Trial of EB613 at the 2025 North American Menopause Society (NAMS) Annual Meeting (GlobeNewswire)
Sep-18-25 08:41AM	Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy (Zacks)
Aug-08-25 04:05PM	Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
Jul-31-25 04:05PM	OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results (GlobeNewswire)
Jul-28-25 07:30AM	Entera Bio Receives FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study in Post-Menopausal Women with Osteoporosis (GlobeNewswire) +10.75%
Jul-08-25 08:00AM	OPKO Health and Entera Bio Announce Abstract on PK/PD of Oral GLP-2 Tablet for the Treatment of Short Bowel Syndrome Selected for 2025 ESPEN Congress (GlobeNewswire)
08:00AM	Loading…
Jun-26-25 08:00AM	Entera Bio Data for EB613 Effects on Trabecular and Cortical Bone in Post-Menopausal Women with Osteoporosis Selected for Oral Presentation at ASBMR 2025 Annual Meeting (GlobeNewswire)
Jun-25-25 08:00AM	OPKO Health and Entera Bio Abstract for First-in-Class Dual GLP-1/Glucagon Tablet Candidate for Patients with Obesity and Metabolic Disorders Selected for Presentation at the ENDO 2025 Annual Meeting (GlobeNewswire)
May-09-25 04:05PM	Entera Bio Announces First Quarter 2025 Financial Results and Business Updates (GlobeNewswire)
Apr-15-25 08:30AM	Entera Bio's EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO (GlobeNewswire)
Mar-28-25 04:05PM	Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-18-25 11:37AM	Opko and Entera focus on oral care for obesity and metabolic disorders (Pharmaceutical Technology)
Mar-17-25 08:00AM	OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders (GlobeNewswire)
Feb-24-25 08:30AM	Entera Bio to Participate in Upcoming Events (GlobeNewswire)
Feb-19-25 08:00AM	EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (GlobeNewswire)
Jan-27-25 08:00AM	Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Nov-08-24 05:15PM	Entera Bio Ltd. (ENTX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Entera Bio Reports Q3 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Sep-25-24 08:30AM	Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders (GlobeNewswire)
Sep-18-24 09:40AM	Is Entera Bio (ENTX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Sep-02-24 09:40AM	Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year? (Zacks)
08:00AM	Loading…
Aug-20-24 08:00AM	Entera Bio to Participate in Upcoming Investor and Scientific Conferences (GlobeNewswire)
Aug-15-24 12:00PM	All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy (Zacks)
Aug-09-24 04:05PM	Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-01-24 08:30AM	Entera's EB613, the First Once Daily PTH(1-34) Tablet Treatment Dedicated to Post-Menopausal Women with High Risk Osteoporosis Abstract Selected for Presentation at the ASBMR 2024 Annual Meeting - Key SABRE Update Also Expected (GlobeNewswire)
Jul-23-24 06:28AM	3 Meme Stocks to Buy and Hold for Potential 300% Returns in 3 Years (InvestorPlace)
Jul-08-24 03:53PM	3 Meme Stocks That Can Surge by 200% Before 2025 (InvestorPlace) +5.99%
Jul-02-24 05:05PM	3 Clinical-Stage Biotech Stocks to Buy for Multibagger Returns (InvestorPlace)
Jun-25-24 04:37PM	3 Meme Stocks to Buy on the Dip: June 2024 (InvestorPlace) -9.22%
Jun-20-24 12:38PM	7 Penny Stocks to Turn $3 Into $1 Million Within 36 Months (InvestorPlace)
06:47AM	Rags to Riches: 3 Penny Stocks That Could Make Early Investors Rich (InvestorPlace)
06:47AM	Rag to Riches: 3 Penny Stocks That Could Make Early Investors Rich (InvestorPlace)
Jun-17-24 01:00PM	3 Penny Stocks to Turn $50,000 Into $1 Million: June 2024 (InvestorPlace)
Jun-10-24 07:22PM	Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024 (InvestorPlace)
Jun-07-24 07:30AM	Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar (InvestorPlace)
Jun-03-24 09:40AM	Has Entera Bio (ENTX) Outpaced Other Medical Stocks This Year? (Zacks)
08:00AM	Entera Bio Reports Phase 1 Clinical Data of First-in-Class, Oral PTH(1-34) Peptide Candidate (EB612) for Patients with Hypoparathyroidism at ENDO 2024 (GlobeNewswire)
May-23-24 06:45AM	The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom (InvestorPlace)
May-16-24 09:40AM	Are Medical Stocks Lagging Entera Bio (ENTX) This Year? (Zacks)
May-15-24 08:00AM	Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member (GlobeNewswire)
May-13-24 07:00AM	Entera Bio to Present Phase 1 Data from First-in-Class, PTH(1-34) Peptide Tablets (EB612) for the Treatment of Hypoparathyroidism at ENDO 2024 (GlobeNewswire)
May-10-24 08:53PM	ENTX Stock Earnings: Entera Bio Beats EPS for Q1 2024 (InvestorPlace)
04:10PM	Entera Bio Reports Q1 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Apr-26-24 06:00PM	Entera Bio Ltd. (ENTX) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
Apr-18-24 06:15PM	Why the Market Dipped But Entera Bio Ltd. (ENTX) Gained Today (Zacks) -11.16%
Apr-15-24 03:43PM	Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024? (InvestorPlace) -15.44%
Apr-12-24 09:40AM	Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year? (Zacks) +12.03%
Apr-09-24 09:09AM	Here's Why You Should Invest in Entera Bio (ENTX) Stock Now (Zacks) +15.38%
Apr-08-24 08:30AM	Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research (GlobeNewswire)
Mar-26-24 08:30AM	Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months (GlobeNewswire)
Mar-24-24 03:54PM	12 Best Biotech Penny Stocks to Invest In (Insider Monkey)
Mar-20-24 08:00AM	Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome (GlobeNewswire) +7.79%
Mar-08-24 04:05PM	Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates (GlobeNewswire) +5.04%
Mar-04-24 08:30AM	Entera Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire) +19.44%
Jan-30-24 08:30AM	Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Jan-03-24 08:00AM	Entera Bio Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule (GlobeNewswire)
Dec-26-23 08:00AM	Entera Bio Announces Closing of Private Placement - Extends Cash Runway into 2025 (GlobeNewswire)
Nov-29-23 08:30AM	Interim Results from Ongoing Clinical Study Confirm EB613 Optimized Profile for Osteoporosis Treatment and Potential for Entera's Next Generation Oral Peptide Platform (GlobeNewswire)
Nov-14-23 07:30AM	Entera Bio Reports Q3 2023 Financial Results, Highlights Transformational Steps and Unveils Vision as Premier Oral Peptide Company with Five Potential Programs in Development (GlobeNewswire)
Nov-09-23 02:30PM	Entera Bio Reports Key Milestone Relating to Oral PTH (1-34) Peptide (EB613) Phase 3 Program: ASBMR-SABRE Has Submitted to FDA the Full Qualification Plan to Approve BMD as a Surrogate Endpoint for Osteoporosis (GlobeNewswire) +20.64%
Oct-16-23 08:00AM	Entera Bio Reports Rapid Pharmacodynamic (PD) Response and Consistent Pharmacokinetic (PK) Data for its First-in-Class Oral PTH(1-34) Mini Tablets at the ASBMR 2023 Annual Meeting (GlobeNewswire)
Sep-13-23 01:18PM	OPKO Health (OPK) Ties Up for Oral Peptide Tablet Formulations (Zacks)
Sep-12-23 08:30AM	Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes (GlobeNewswire)
Sep-05-23 08:00AM	Entera Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-16-23 08:30AM	Entera Bio to Present Two Abstracts on its First-in-Class, Once Daily Oral hPTH(1-34) Peptide Tablets (EB613) for the Treatment of Post-Menopausal Women at High Risk of Fracture at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting (GlobeNewswire) +5.02%
Aug-11-23 04:05PM	Entera Bio Announces Q2 2023 Financial Results and Corporate Updates (GlobeNewswire) -17.57%
Jun-07-23 07:30AM	Entera Bio Adds Sanofi Commercial Leader, Haya Taitel to its Board of Directors (GlobeNewswire)
May-07-23 08:10AM	Entera Bio First Quarter 2023 Earnings: US$0.076 loss per share (vs US$0.13 loss in 1Q 2022) (Simply Wall St.)
May-05-23 05:15PM	Entera Bio Ltd. (ENTX) Reports Q1 Loss, Misses Revenue Estimates (Zacks) -6.70% +7.30%
04:05PM	Entera Bio Announces Q1 2023 Financial Results and Corporate Updates (GlobeNewswire)
May-04-23 10:00AM	Will Entera Bio Ltd. (ENTX) Report Negative Q1 Earnings? What You Should Know (Zacks)
May-03-23 09:34AM	Enteras Oral Delivery of GLP-2 Pre-Clinical Data to be Published in Peer Reviewed, International Journal of Peptide Research and Therapeutics (GlobeNewswire) +10.00%
Apr-26-23 08:30AM	Menopause Luminary, Dr. Steven R. Goldstein, Joins Enteras Clinical and Scientific Advisory Board (GlobeNewswire)
Apr-03-23 07:00AM	Entera Bio Provides Guidance from FDA Type D Meeting Related to EB613 Pivotal Program (GlobeNewswire) -13.36%
Mar-31-23 05:15PM	Entera Bio Ltd. (ENTX) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:00PM	Entera Bio Provides 2022 Corporate Milestones and Financial Results for the Year Ended December 31, 2022 (GlobeNewswire)
Mar-23-23 09:27AM	Entera Bio Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Mar-10-23 08:05AM	Will Entera Bio (NASDAQ:ENTX) Spend Its Cash Wisely? (Simply Wall St.)
Feb-20-23 08:34AM	Entera Bio (ENTX) to Report Q4 Earnings: What's in the Cards? (Zacks)
Feb-15-23 10:00AM	Entera Bio Announces FDAs Acceptance of a Type D Meeting Review to Affirm Design of the Pivotal, Phase 3 Protocol for EB613 PTH Mini Tablets, as the First Oral Osteoanabolic Treatment of Post-Menopausal Osteoporosis (GlobeNewswire) +10.99%
Feb-13-23 09:00AM	Entera Bio to Participate in the SVB Securities Global Biopharma Conference (GlobeNewswire)
Feb-10-23 06:00PM	Entera Bio Ltd. (ENTX) Outpaces Stock Market Gains: What You Should Know (Zacks)
Feb-02-23 06:00PM	Entera Bio Ltd. (ENTX) Flat As Market Gains: What You Should Know (Zacks)
Jan-27-23 06:00PM	Entera Bio Ltd. (ENTX) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-25-23 06:15PM	Entera Bio Ltd. (ENTX) Flat As Market Sinks: What You Should Know (Zacks)
Jan-18-23 06:15PM	Entera Bio Ltd. (ENTX) Gains As Market Dips: What You Should Know (Zacks)
Nov-16-22 07:27AM	New Strong Buy Stocks for November 16th (Zacks) +15.76%
Nov-10-22 05:45PM	Entera Bio Ltd. (ENTX) Reports Q3 Loss, Misses Revenue Estimates (Zacks) -19.20%
04:15PM	Entera Bio Provides Corporate Updates and Financial Results for the Third Quarter of 2022 (GlobeNewswire)
Oct-06-22 07:00AM	Entera Bio Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support an NDA for EB613 for the Treatment of Osteoporosis (GlobeNewswire)
Oct-01-22 08:28AM	Is Entera Bio (NASDAQ:ENTX) In A Good Position To Invest In Growth? (Simply Wall St.)

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Rubin Steven D	Director	Feb 09 '26	Buy	1.20	10,000	12,000	10,000	Feb 11 08:44 AM
Ellis Sean	Director	Feb 09 '26	Buy	1.24	18,000	22,320	178,098	Feb 11 08:42 AM
Toledano Miranda Jayne	Chief Executive Officer	Dec 29 '25	Buy	1.81	11,000	19,912	426,575	Dec 30 06:01 AM
LIEBERMAN GERALD M	Director	Apr 01 '25	Option Exercise	1.00	23,952	23,952	300,160	Apr 03 04:06 PM

Open in Screener

RDVT

Red Violet Inc

Feb 13 • 04:00PM ET

41.66

+1.05 2.59 %

Technology • Software - Application • USA • NASD

Peers: TRU EFX FICO SPGI CSGP VRSK MSCI DNB ACN IT

| Held by: VTI VGT IWM VXF IWO VTWO SCHA XSW FSMD DFAS

Index	RUT	P/E	54.09	EPS (ttm)	0.77	Insider Own	21.44%	Shs Outstand	13.97M	Perf Week	2.16%
Market Cap	586.92M	Forward P/E	32.55	EPS next Y	1.28	Insider Trans	-1.79%	Shs Float	11.07M	Perf Month	-18.10%
Enterprise Value	544.43M	PEG	2.25	EPS next Q	0.14	Inst Own	68.01%	Short Float	6.30%	Perf Quarter	-28.15%
Income	11.20M	P/S	6.79	EPS this Y	40.85%	Inst Trans	0.41%	Short Ratio	6.51	Perf Half Y	-4.69%
Sales	86.42M	P/B	5.72	EPS next Y	10.82%	ROA	10.67%	Short Interest	0.70M	Perf YTD	-26.85%
Book/sh	7.28	P/C	12.94	EPS next 5Y	14.47%	ROE	11.58%	52W High	64.14 -35.04%	Perf Year	-1.63%
Cash/sh	3.22	P/FCF	20.32	EPS past 3/5Y	116.44% -	ROIC	10.75%	52W Low	32.23 29.26%	Perf 3Y	80.67%
Dividend Est.	-	EV/EBITDA	24.42	Sales past 3/5Y	19.53% 19.95%	Gross Margin	71.49%	Volatility	4.77% 5.34%	Perf 5Y	60.39%
Dividend TTM	-	EV/Sales	6.30	EPS Y/Y TTM	117.93%	Oper. Margin	13.78%	ATR (14)	2.26	Perf 10Y	-
Dividend Ex-Date	Jan 31, 2025	Quick Ratio	8.39	Sales Y/Y TTM	22.27%	Profit Margin	12.96%	RSI (14)	34.09	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.39	EPS Q/Q	139.97%	SMA20	-7.06%	Beta	1.68	Target Price	68.50
Payout	0.00%	Debt/Eq	0.03	Sales Q/Q	21.13%	SMA50	-17.52%	Rel Volume	0.59	Prev Close	40.61
Employees	215	LT Debt/Eq	0.02	Earnings	Nov 05 AMC	SMA200	-15.74%	Avg Volume	107.10K	Price	41.66
IPO	Mar 26, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	24.84% 1.95%	Trades		Volume	62,668	Change	2.59%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-04-25	Initiated	Lake Street	Buy	$60
Mar-26-24	Initiated	B. Riley Securities	Buy	$25

Feb-13-26 08:00AM	FOREWARN to Provide Identity Verification Services to West Penn Multi-List, Inc. to Promote Agent Safety (GlobeNewswire)
Jan-15-26 08:00AM	FOREWARN to Provide Identity Verification Services to Spokane REALTORS to Promote Agent Safety (GlobeNewswire)
Jan-05-26 08:00AM	red violet to Present at the 28th Annual Needham Growth Conference (GlobeNewswire)
Dec-10-25 08:58AM	Is the Options Market Predicting a Spike in Red Violet Stock? (Zacks)
Dec-01-25 12:45PM	Is Red Violet (RDVT) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
10:14AM	Loading…
Nov-25-25 10:14AM	Are These 3 Under-the-Radar AI Stocks the Next Big Growth Stories? (MarketBeat)
Nov-13-25 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Red Violet (RDVT) (Zacks)
12:20PM	Earnings Estimates Rising for Red Violet (RDVT): Will It Gain? (Zacks)
12:00PM	What Makes Red Violet (RDVT) a New Buy Stock (Zacks)
Nov-12-25 06:58AM	Nebius' Q3 Loss Widens Y/Y, Revenues Rise on AI Demand, Stock Down (Zacks)
Nov-11-25 08:00AM	red violet to Present at the Raymond James TMT and Consumer Conference (GlobeNewswire)
Nov-07-25 09:30AM	red violet Named to TIME's America's Growth Leaders of 2026 List (GlobeNewswire)
Nov-06-25 12:04AM	Red Violet Inc (RDVT) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com) +8.97%
Nov-05-25 06:50PM	Red Violet, Inc. (RDVT) Tops Q3 Earnings and Revenue Estimates (Zacks)
04:05PM	red violet Announces Third Quarter 2025 Financial Results (GlobeNewswire)
07:15AM	Loading…
07:15AM	Meta Slumps on AI Spending, Echoing 2022 Metaverse Rout (Bloomberg)
Nov-04-25 08:15AM	Red Violet Inc (RDVT) Q3 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
08:00AM	red violet to Present at the Southwest IDEAS Investor Conference (GlobeNewswire)
Nov-03-25 05:25PM	RingCentral (RNG) Tops Q3 Earnings and Revenue Estimates (Zacks)
08:00AM	FOREWARN to Provide Identity Verification Services to Massachusetts Association of REALTORS to Promote Agent Safety (GlobeNewswire)
Oct-30-25 05:15PM	Arrow Electronics (ARW) Beats Q3 Earnings and Revenue Estimates (Zacks)
Oct-29-25 08:00AM	FOREWARN to Provide Identity Verification Services to Salt Lake Board of REALTORS to Promote Agent Safety (GlobeNewswire)
Oct-23-25 08:00AM	FOREWARN to Provide Identity Verification Services to REALTOR Alliance of Greater Cincinnati to Promote Agent Safety (GlobeNewswire)
Oct-22-25 04:05PM	red violet to Announce Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire)
Oct-21-25 12:21PM	IDI Announces Integration with TazWorks to Expand Access to IDI's Best-in-Class Identity Intelligence in the Background Screening Industry (GlobeNewswire)
Oct-20-25 08:00AM	IDI Announces Integration with TazWorks to Expand Access to IDI's Best-in-Class Identity Intelligence in the Background Screening Industry (GlobeNewswire)
Sep-08-25 08:00AM	FOREWARN to Provide Identity Verification Services to Pacific Regional Multiple Listing Service to Promote Agent Safety (GlobeNewswire)
Aug-21-25 04:05PM	red violet to Present at the Midwest IDEAS Investor Conference (GlobeNewswire) +5.22%
Aug-18-25 11:11AM	Globant Q2 Earnings & Revenues Beat Estimates, Stock Down (Zacks)
Aug-08-25 10:05AM	Nebius' Q2 Loss Widens Y/Y, Revenues Rise on AI Demand, Stock Up (Zacks)
06:25PM	Loading…
Aug-06-25 06:25PM	Red Violet, Inc. (RDVT) Matches Q2 Earnings Estimates (Zacks)
04:05PM	red violet Announces Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-05-25 05:35PM	RingCentral (RNG) Beats Q2 Earnings and Revenue Estimates (Zacks)
10:11AM	Red Violet Inc (RDVT) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Jul-30-25 05:45PM	Tyler Technologies (TYL) Q2 Earnings and Revenues Top Estimates (Zacks)
Jul-23-25 08:00AM	red violet to Announce Second Quarter 2025 Financial Results on August 6, 2025 (GlobeNewswire)
Jul-01-25 01:15PM	WNS (Holdings) Stock Scores RS Rating Upgrade To 81 (Investor's Business Daily)
08:00AM	FOREWARN to Provide Identity Verification Services to MIBOR REALTOR Association to Promote Agent Safety (GlobeNewswire)
07:48AM	Here's Riverwater Partners Micro Opportunities Strategy's Thesis for Red Violet (RDVT) (Insider Monkey)
Jun-30-25 12:03PM	Red Violet (RDVT) Surges 6.3%: Is This an Indication of Further Gains? (Zacks)
08:50AM	Recent Price Trend in Red Violet (RDVT) is Your Friend, Here's Why (Zacks)
Jun-12-25 10:25AM	Nebius Expands AI Cloud in Europe With NVIDIA GB200 and Blackwell (Zacks)
Jun-09-25 10:11AM	Globant Unveils AI Pods to Revolutionize IT Services Delivery Model (Zacks)
Jun-05-25 08:00AM	FOREWARN to Provide Identity Verification Services to Mid Jersey Association of REALTORS to Promote Agent Safety (GlobeNewswire)
Jun-02-25 12:45PM	Is Red Violet (RDVT) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
12:00PM	Red Violet, Inc. (RDVT) is a Great Momentum Stock: Should You Buy? (Zacks)
08:50AM	Red Violet (RDVT) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
May-30-25 01:12AM	Red Violet, Inc. (RDVT): A Bull Case Theory (Insider Monkey)
May-29-25 03:46PM	Aramark Stock Sees Relative Strength Rating Rise To 84 (Investor's Business Daily)
May-28-25 08:00AM	red violet to Present at the East Coast IDEAS Investor Conference (GlobeNewswire)
May-16-25 12:45PM	Red Violet (RDVT) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
12:20PM	Why Red Violet (RDVT) Might be Well Poised for a Surge (Zacks)
12:00PM	Red Violet, Inc. (RDVT) Is Up 15.05% in One Week: What You Should Know (Zacks)
08:50AM	Here's Why Momentum in Red Violet (RDVT) Should Keep going (Zacks)
May-13-25 08:00AM	red violet to Present at the 25th Annual B. Riley Securities Investor Conference (GlobeNewswire)
May-08-25 08:00AM	FOREWARN to Provide Identity Verification Services to NEXUS Association of REALTORS to Promote Agent Safety (GlobeNewswire) +15.20%
03:30AM	Red Violet Inc (RDVT) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com)
May-07-25 08:14PM	Red Violet, Inc. (RDVT) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:05PM	Red Violet, Inc. (RDVT) Q1 Earnings and Revenues Top Estimates (Zacks)
04:05PM	red violet Announces First Quarter 2025 Financial Results (GlobeNewswire)
09:35AM	Netflix Investors Unfazed by Tariffs With Growth Engine Humming (Bloomberg)
May-05-25 04:05PM	red violet to Participate in the 20th Annual Needham Technology, Media, & Consumer Conference (GlobeNewswire)
08:00AM	IDI Integrates with Ping Identity's PingOne DaVinci to Deliver Powerful Identity Insights Across the Consumer Journey (GlobeNewswire)
May-01-25 02:01PM	ExlService Holdings Stock Gets RS Rating Bump To 93 (Investor's Business Daily)
Apr-29-25 12:34PM	Teradyne Q1 Earnings Surpass Estimates, Revenues Increase Y/Y (Zacks)
Apr-23-25 08:00AM	red violet to Announce First Quarter 2025 Financial Results on May 7, 2025 (GlobeNewswire)
Apr-14-25 08:00AM	FOREWARN to Provide Identity Verification Services to HiCentral MLS to Promote Agent Safety (GlobeNewswire)
Apr-04-25 08:00AM	FOREWARN to Provide Identity Verification Services to Little Rock REALTORS Association to Promote Agent Safety (GlobeNewswire)
Mar-25-25 08:50AM	Red Violet (RDVT) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Mar-18-25 08:00AM	FOREWARN to Provide Identity Verification Services to Willamette Valley Multiple Listing Service to Promote Agent Safety (GlobeNewswire)
Mar-05-25 08:00AM	red violet Announces Appointment of Greg Strakosch to Board of Directors (GlobeNewswire)
Feb-28-25 09:39AM	Q4 2024 Red Violet Inc Earnings Call (Thomson Reuters StreetEvents) +6.84%
02:39AM	Red Violet Inc (RDVT) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Feb-27-25 04:05PM	red violet Announces Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-26-25 08:06AM	What To Expect From Red Violet Inc (RDVT) Q4 2024 Earnings (GuruFocus.com)
Feb-19-25 08:00AM	FOREWARN to Provide Identity Verification Services to Denver Metro Association of REALTORS to Promote Agent Safety (GlobeNewswire)
Feb-13-25 08:00AM	red violet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 (GlobeNewswire) +5.17%
Feb-06-25 08:30AM	FOREWARN to Provide Identity Verification Services to Greater Fort Worth Association of REALTORS to Promote Agent Safety (GlobeNewswire)
Jan-13-25 08:00AM	FOREWARN to Provide Identity Verification Services to Greater Baltimore Board of REALTORS to Promote Agent Safety (GlobeNewswire)
Dec-13-24 08:00AM	FOREWARN Partners with Bluegrass REALTORS (GlobeNewswire)
Dec-04-24 08:00AM	Red Violet board declares special cash dividend of 30c per share (TipRanks)
Dec-03-24 07:55AM	red violet Announces Special Cash Dividend Reflecting Operational Strength and Robust Cash Flow Generation (GlobeNewswire)
Nov-18-24 09:55AM	Red Violet (RDVT) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (Zacks)
Nov-12-24 08:00AM	FOREWARN Partners with MetroTex Association of REALTORS (GlobeNewswire)
Nov-07-24 02:00PM	Red Violet Inc (RDVT) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com) +5.65%
Nov-06-24 06:25PM	Red Violet, Inc. (RDVT) Lags Q3 Earnings Estimates (Zacks) +7.30%
04:05PM	red violet Announces Third Quarter 2024 Financial Results (GlobeNewswire)
08:00AM	red violet to Participate in the Southwest IDEAS Investor Conference (GlobeNewswire)
Nov-04-24 08:00AM	FOREWARN Partners with Triad Multiple Listing Service (GlobeNewswire)
Oct-23-24 08:00AM	red violet to Announce Third Quarter 2024 Financial Results on November 6, 2024 (GlobeNewswire)
Oct-21-24 10:04AM	Red Violet (RDVT) Soars 7.6%: Is Further Upside Left in the Stock? (Zacks)
Oct-18-24 08:00AM	FOREWARN Partners with New Hampshire Association of REALTORS (GlobeNewswire) +7.57%
Oct-08-24 08:14AM	Red Violet (RDVT) Delivered Strong Results in Q3 (Insider Monkey)
Sep-09-24 08:00AM	FOREWARN Partners with Howard County Association of REALTORS (GlobeNewswire)
Aug-13-24 10:31AM	REPEAT -- IDI Now Available on Carahsoft's GSA Schedule (GlobeNewswire)
08:23AM	IDI Now Available on Carahsoft's GSA Schedule (GlobeNewswire)
Aug-08-24 01:03PM	Q2 2024 Red Violet Inc Earnings Call (Thomson Reuters StreetEvents) +14.80%
08:00AM	red violet to Participate in the Midwest IDEAS Investor Conference (GlobeNewswire)
Aug-07-24 06:25PM	Red Violet, Inc. (RDVT) Tops Q2 Earnings and Revenue Estimates (Zacks) +7.26%
04:05PM	red violet Announces Second Quarter 2024 Financial Results (GlobeNewswire)

Red Violet, Inc. engages in the provision of software and proprietary technology services. It specializes in data and analysis sector, which provides cloud-based, mission-critical information solutions to enterprises in a variety of industries. Its brands include IDI and Forewarn. The company was founded in August 2017 and is headquartered in Boca Raton, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DELL JEFFREY ALAN	Chief Information Officer	Nov 10 '25	Sale	58.11	4,671	271,439	161,263	Nov 13 06:22 PM
DELL JEFFREY ALAN	Chief Information Officer	Nov 12 '25	Sale	57.85	2,733	158,097	157,074	Nov 13 06:22 PM
DELL JEFFREY ALAN	Chief Information Officer	Nov 11 '25	Sale	57.81	1,456	84,171	159,807	Nov 13 06:22 PM
DELL JEFFREY ALAN	Chief Information Officer	Nov 13 '25	Sale	56.95	1,140	64,923	155,934	Nov 13 06:22 PM
Dubner Derek	Chief Executive Officer	Nov 10 '25	Sale	58.11	7,006	407,130	563,994	Nov 13 06:21 PM
Dubner Derek	Chief Executive Officer	Nov 12 '25	Sale	57.85	4,099	237,120	557,711	Nov 13 06:21 PM
Dubner Derek	Chief Executive Officer	Nov 11 '25	Sale	57.81	2,184	126,257	561,810	Nov 13 06:21 PM
Dubner Derek	Chief Executive Officer	Nov 13 '25	Sale	56.95	1,711	97,435	556,000	Nov 13 06:21 PM
MacLachlan Daniel	Chief Financial Officer	Nov 10 '25	Sale	58.11	7,006	407,129	366,157	Nov 13 06:19 PM
MacLachlan Daniel	Chief Financial Officer	Nov 12 '25	Sale	57.85	4,099	237,118	359,874	Nov 13 06:19 PM
MacLachlan Daniel	Chief Financial Officer	Nov 11 '25	Sale	57.81	2,184	126,257	363,973	Nov 13 06:19 PM
MacLachlan Daniel	Chief Financial Officer	Nov 13 '25	Sale	56.95	1,711	97,438	358,163	Nov 13 06:19 PM
Reilly James Patrick	President	Nov 10 '25	Sale	58.11	7,006	407,130	239,072	Nov 13 06:18 PM
Reilly James Patrick	President	Nov 12 '25	Sale	57.85	4,099	237,118	232,789	Nov 13 06:18 PM
Reilly James Patrick	President	Nov 11 '25	Sale	57.81	2,184	126,257	236,888	Nov 13 06:18 PM
Reilly James Patrick	President	Nov 13 '25	Sale	56.95	1,711	97,439	231,078	Nov 13 06:18 PM
Jeffrey Alan Dell	Officer	Nov 10 '25	Proposed Sale	58.20	10,000	582,000		Nov 10 09:31 PM
Derek Dubner	Officer	Nov 10 '25	Proposed Sale	58.20	15,000	873,000		Nov 10 09:30 PM
Daniel MacLachlan	Officer	Nov 10 '25	Proposed Sale	58.20	15,000	873,000		Nov 10 09:30 PM
James P. Reilly	Officer	Nov 10 '25	Proposed Sale	58.20	15,000	873,000		Nov 10 09:27 PM
DELL JEFFREY ALAN	Chief Information Officer	May 09 '25	Sale	46.20	5,000	231,018	172,968	May 09 07:59 PM
Dubner Derek	Chief Executive Officer	May 09 '25	Sale	46.21	10,000	462,096	580,379	May 09 07:58 PM
MacLachlan Daniel	Chief Financial Officer	May 09 '25	Sale	46.21	10,000	462,096	382,917	May 09 07:57 PM
Reilly James Patrick	President	May 09 '25	Sale	46.21	10,000	462,096	255,457	May 09 07:56 PM
James P. Reilly	Officer	May 09 '25	Proposed Sale	46.62	10,000	466,200		May 09 07:41 PM
Daniel MacLachlan	Officer	May 09 '25	Proposed Sale	46.62	10,000	466,200		May 09 07:40 PM
Derek Dubner	Officer	May 09 '25	Proposed Sale	46.62	10,000	466,200		May 09 07:38 PM
Jeffrey Alan Dell	Officer	May 09 '25	Proposed Sale	46.62	5,000	233,100		May 09 07:37 PM
Rubin Steven D	Director	Mar 19 '25	Sale	38.93	10,000	389,300	141,138	Mar 21 06:30 PM
Rubin Steven D	Director	Mar 19 '25	Proposed Sale	38.93	10,000	389,307		Mar 19 04:41 PM
Stanton Lisa M.	Director	Mar 07 '25	Buy	36.12	1,000	36,120	26,815	Mar 10 04:30 PM
BENZ PETER	Director	Mar 06 '25	Proposed Sale	37.75	20,000	755,000		Mar 06 12:40 PM

ENTX

Entera Bio Ltd

RDVT

Red Violet Inc

Upgrade your FINVIZ experience